Day: November 7, 2024

Nyxoah Reports Third Quarter Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating Results FDA approval on track for first quarter 2025, U.S. commercial team build out in progress Company fully funded with cash until mid 2026 Mont-Saint-Guibert, Belgium – November 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough

Search Here

Popular News

Gaming Unites Global Community at 2026 Esports World Cup

Riyadh: At the 2026 Esports World Cup in Paris, people from diverse backgrounds and cultures are united by a shared passion for gaming, transcending national borders and language barriers.

According to Saudi Press Agency, the lens of the agency capt…

MENU

CATEGORIES